OverT Bio

OverT Bio is a New York-based biotechnology company developing safe and effective cellular therapies for solid tumors. They utilize innovative pooled functional screening and synthetic genomics platforms (_OverT_argetTM and _OverT_CRTM) to identify new therapeutic targets and genetic enhancements for cancer patients.

Buy Funded Startups lists

Funding Round: Grant

Funding Amount: $120K

Date: 22-Nov-2024

Investors: ScaleReady

Markets: Biotechnology, Cell Therapy, Oncology, Life Science, Therapeutics, Drug Discovery, HealthTech

HQ: New York, New York, United States

Founded: 2022

Website: https://www.overt.bio/

LinkedIn: https://www.linkedin.com/company/overt-bio

Twitter: https://twitter.com/OverT_Bio

Instagram: